CSNK1D rs397514693: Sleep Rhythms and Circadian Timing

What each genotype means

Genetic Overview and Molecular Location

The single nucleotide polymorphism rs397514693 is located on human chromosome 17 within the CSNK1D gene. At the nucleotide level, the variant reflects a single-base change that alters an amino acid in the encoded protein, swapping an invariant histidine for an arginine. Depending on the protein isoform and reference transcript consulted, this alteration is referred to in the medical literature as p.His46Arg or p.His205Arg. Casein kinase 1 delta relies on this highly conserved region to maintain its enzymatic architecture. Because amino acid substitutions can subtly or significantly impair protein folding, substrate binding, or catalytic activity, alterations at this position have generated significant scientific interest regarding how single amino acids tune the precision of the human internal molecular clock.

Function of the CSNK1D Gene

The CSNK1D gene encodes casein kinase 1 delta (CKIδ), a ubiquitous serine/threonine protein kinase expressed throughout human tissues and heavily enriched in the central nervous system. CKIδ plays a central regulatory role in cellular phosphorylation cascades, most notably in circadian rhythms. Within the molecular feedback loops that govern daily biological timing, CKIδ phosphorylates core clock components, including the PERIOD (PER) family of proteins. This phosphorylation directs the stability, nuclear accumulation, and timed degradation of these proteins over roughly 24-hour cycles. By ensuring that clock proteins break down and regenerate at regular intervals, CKIδ functions as a molecular escapement mechanism, stabilizing the cellular pacemaker that governs sleep onset, core body temperature dips, and hormonal secretions.

Associated Traits and Strength of Evidence

The primary clinical association documented for rs397514693 is familial advanced sleep phase syndrome type 2 (FASPS2), an autosomal dominant condition characterized by an internal clock that runs significantly advanced relative to societal norms. Individuals with this condition typically fall asleep early in the evening (often between 6:00 PM and 8:30 PM) and wake naturally in the early morning hours (between 2:00 AM and 5:00 AM) while maintaining normal sleep architecture. In vitro functional assays demonstrated that the mutant enzyme exhibits a substantial reduction in kinase activity compared to the wild-type enzyme. However, because this variant was identified in small family pedigrees, population-scale evidence is classified as limited. Broader population biobank studies note that Mendelian sleep variants often exhibit variable penetrance outside of tightly ascertained families.

Population Frequency and Distribution

Across large human population datasets, including the Genome Aggregation Database (gnomAD), rs397514693 is virtually absent or observed at an extremely low allele frequency (below 0.00005). Because it is exceptionally rare, reliable differences in frequency across distinct global ancestries have not been established. The standard reference allele is overwhelmingly conserved across all human populations and mammalian species. Identifying this variant in standard consumer genotyping arrays or clinical whole-exome sequencing panels is uncommon, and its appearance in the scientific literature is largely confined to targeted neurogenetic investigations of multigenerational families with distinct circadian rhythm presentations.

Practical Implications and What to Consider

Carrying an atypical genotype at rs397514693 does not serve as an automatic clinical diagnosis, nor does it replace comprehensive medical evaluation. Sleep timing is a multifactorial trait influenced by polygenic inheritance, age, daylight exposure, shift work, and societal habits. Being an early riser or 'morning lark' is common and usually reflects common polygenic variation or behavioral routines rather than a rare pathogenic mutation. If you or family members experience extreme early sleepiness or premature awakening that causes distress or impairs daytime function, consulting a sleep specialist or medical geneticist can help evaluate circadian patterns. Genetic findings should always be interpreted within the context of actual clinical presentation rather than direct-to-consumer data alone.

Frequently asked questions

Sources & further reading

Related variants in CSNK1D